$Pfizer(PFE)$ PFE got a nice boost from its recent strategic investments/acquisitions. Those investments will take time to produce income. However, PFE is becoming a much stronger company going forward. 22 should be PFE's best yearly earnings ever, and I believe it will carry over into 23 as their vaccine and covid treatment will still be in demand. I am surprised to see it fall so hard the last couple of days, but I still believe in the company as the best diversified large pharma plays. I look forward to PFE/Bourla's presentation this coming Monday. I am sure they will have a lot of positives to report. I expect even higher revenue and earnings projections, and a detailed update on its pipeline successes and potential.